Sigyn Therapeutics, Inc. announced the appointment of Jeremy Ferrell, CPA, MBA as Chief Financial Officer (“CFO”), effective March 9, 2022. As CFO, Mr. Ferrell will have overall responsibility for operational finance, budgeting, and financial reporting, as well as helping to manage Sigyn's relationships and interactions with the investment community. Mr. Ferrell has more than 25 years of finance and operations leadership experience, with expertise in venture capital; mergers and acquisitions; due diligence; initial public offerings; strategic alliance negotiation; and financial planning and reporting.

He was most recently CFO at Miku, Inc, a privately held consumer hardware and tele-health company, where he managed a successful seed financing round and led Miku's transition from its parent to an independent company.